PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $9,765,000 | -23.6% | 1,392,997 | 0.0% | 0.59% | -16.5% |
Q2 2021 | $12,788,000 | -5.6% | 1,392,997 | 0.0% | 0.70% | -8.6% |
Q1 2021 | $13,540,000 | -3.9% | 1,392,997 | +1.4% | 0.77% | +4.3% |
Q4 2020 | $14,096,000 | +2.1% | 1,373,897 | +0.4% | 0.74% | -2.5% |
Q3 2020 | $13,806,000 | -1.5% | 1,368,317 | +1.8% | 0.76% | -10.0% |
Q2 2020 | $14,017,000 | +18.9% | 1,343,897 | -3.7% | 0.84% | -14.7% |
Q1 2020 | $11,784,000 | -0.2% | 1,396,163 | +3.5% | 0.99% | +51.8% |
Q4 2019 | $11,805,000 | -22.0% | 1,349,180 | -4.0% | 0.65% | -35.5% |
Q3 2019 | $15,132,000 | -15.3% | 1,405,680 | 0.0% | 1.01% | +16.0% |
Q2 2019 | $17,866,000 | -61.0% | 1,405,680 | +19.0% | 0.87% | -54.5% |
Q1 2019 | $45,802,000 | +94.0% | 1,180,780 | +1.8% | 1.91% | +52.0% |
Q4 2018 | $23,604,000 | – | 1,159,900 | – | 1.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |